共 37 条
- [1] Rouge N.(1997)Screening of potentially floating excipients for Minitablets S.T.P. Pharm. Sci. 7 386-392
- [2] Cole E. T.(1999)Formulation of biphasic release tablets containing slightly soluble drugs Eur. J. Pharm. Biopharm. 48 37-42
- [3] Doelker E.(2002)Comparative evaluation of wet granulation and direct compression methods for preparation of controlled release ranitidine HCL tablets Indian J. Pharm. Sci. 64 285-125
- [4] Buri P.(1990)Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases Clin. Pharmacokinet. 19 94-870
- [5] Maggi L.(1989)Ranitidine: an updated review of its pharmacodynamics and pharmacokinetic properties and therapeutic use in peptic ulcer and other allied diseases Drugs. 37 801-165
- [6] Machiste E. O.(2001)Colonic metabolism of ranitidine: implications for its delivery and absorption Int. J. Pharm. 227 157-133
- [7] Torre M. L.(2006)Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note AAPS PharmSciTech. 7 78-74
- [8] Conte U.(2001)Modeling and comparison dissolution profiles Int. J. Pharm. 13 123-204
- [9] Somade S.(1996)Mathematical comparison of curves with an emphasis on Pharm. Tech. 20 64-21
- [10] Singh K.(2000) dissolution profiles PSTT 3 198-184